SOURCE: MedSpas of America, Inc.

June 06, 2008 16:01 ET

MedSpas of America Updates Supply Agreement for the Use of Penzim as Ingredient in Natural Renu

ATLANTA, GA--(Marketwire - June 6, 2008) - MedSpas of America, Inc. (PINKSHEETS: MEDP), www.medspasofamerica.com, announced today that it has updated its worldwide agreement with Zymetech, Inc. from Reykjavick, Iceland, www.zymetech.com, for the use of Penzim as the essential ingredient in the anti-aging line of products for Natural Renu.

Under the trademark of Penzim, Zymetech owns the worldwide patents for an active ingredient called Penzyme derived from enzymes produced by fish, particularly cod in the North Atlantic. This enzyme has been clinically tested for the treatment of pain, inflammation, arthritis, bursitis, eczema, psoriasis, fybromyalgia, acne and other skin conditions, such as itching, dry skin and brown spots.

The Supply Agreement provides the Company worldwide rights to sell Penzim under Natural Renu's trade name in the health and beauty care market sector. The term of the agreement is initially four years with automatic renewals of successive periods of two years at a time.

About Natural Renu

The new division will operate under the brand name of Natural Renu. The company will focus its sales efforts primarily through two marketing channels. The first and primary sales channel shall be the Internet. By utilizing its existing skill set and marketing prowess in this area, the company shall initiate an intensive online awareness campaign and drive potential users of this type of product to its web site. The second target audience shall be to exclusive Dayspas, Resorts and Medspas around the world.

SAFE HARBOR STATEMENT: Except for historical information contained herein, the statements in this release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which may cause a company's actual results in the future to differ materially from forecasted results. These risks and uncertainties include, among other things, product price volatility, product demand, market competition and risk inherent in the operations of a company.

Contact Information

  • Investor Contact Information:

    Paul Smith
    Investor Relations
    1-866-595-1081